Amnio Technology launches PalinGen® InovoFlo™ to supplement tissue for protection, cushioning and lubrication

Wednesday, May 10, 2017 General News
Email Print This Page Comment bookmark
Font : A-A+

PHOENIX, May 10, 2017 /PRNewswire/ -- Amnio Technology, LLC, a leading manufacturer of advanced regenerative allografts derived

from human amniotic tissues, announced the expansion of its product line with the launch of PalinGen® Inov?Floin the summer of 2017.

PalinGen® lnov?Flo is a minimally manipulated liquid allograft

derived from human amniotic fluid and is intended for homologous use to supplement tissue for protection, cushioning and lubrication. The product is supplied in volumes of 0.25 cc, 0.50 cc, 1.0 cc, and 2.0 cc.

Christian Beaudry, Chief Scientific Officer stated, "We are very excited about the launch of Inov?Flo and have expanded our superior amniotic tissue allograft portfolio."

PalinGen® Inov?Flo is manufactured and regulated for human homologous allograft use under 21 CFR Part 1271 and Section 361 of the Public Health Service Act. These tissues are processed and packaged at an FDA registered and American Association of Tissue Banks (AATB) accredited facility.

About Amnio Technology, LLC

Amnio Technology, LLC is a global leader in the development and use of amnion-derived technologies. The company is focused on optimizing the regenerative potential and clinical use of these unique tissues. PalinGen® products do not require fetal sacrifice and recovery is performed with maternal consent during elective Cesarean delivery. Donor tissue is recovered using one of the safest recovery techniques and sterile equipment to minimize bioburden contamination. The amniotic tissues are procured through a network of qualified and trained recovery partners, following stringent screening and recovery protocols in a highly controlled processing environment. Amnio Technology enhances the gift of human birth tissue donation by developing, processing and distributing innovative allografts that provide regenerative therapies to improve quality of life.

PalinGen® is a Registered Trademark of Amnio Technology, LLC. 

Amnio Technology, LLC22510 N 18th DrivePhoenix, AZ 85027Phone: 888.232.8550Fax: 888.232.6750www.amniotechnology.com

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/amnio-technology-launches-palingen-inovflo-to-supplement-tissue-for-protection-cushioning-and-lubrication-300454920.html

SOURCE Amnio Technology, LLC



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor
Advertisement

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook